Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
Знаете ли вы? Кликните два раза на слово, чтобы найти его в TermGallery.
Значения термина nonfatal stroke на английском
Значения для термина "nonfatal stroke" отсутствуют.
Использование термина nonfatal stroke на английском
1
The primary efficacy end point was nonfatal myocardial infarction, nonfatalstroke, or cardiovascular death.
2
Similar nonsignificant associations were observed in stratified analysis for gender, or for fatal and nonfatalstroke.
3
The primary end point is the composite of cardiovascular death, nonfatal myocardial infarction, or nonfatalstroke.
4
The primary outcome was defined as the first occurrence of nonfatalstroke, nonfatal myocardial infarction, or all-cause death.
5
MACE was defined as the first occurrence of all-cause death, nonfatal myocardial infarction, nonfatalstroke, or heart failure hospitalization.
6
Primary objective is a reduction of new major vascular events defined as nonfatalstroke and myocardial infarction or vascular death.
7
The primary cardiovascular outcome was a composite of cardiovascular death, nonfatal myocardial infarction, nonfatalstroke, or hospitalization for unstable angina.
8
Main outcome measures: Total and cardiovascular mortality, all cardiovascular end points, fatal and nonfatalstroke, and fatal and nonfatal cardiac end points.
9
Differences in risk-adjusted rates of death or nonfatalstroke were compared using multiple logistic regression accounting for patient, physician, and hospital-level risk factors.
10
The secondary outcomes were cardiovascular death and major adverse cardiovascular events defined as a composite of cardiovascular death, nonfatal myocardial infarction, and nonfatalstroke.
11
The primary outcome (all cause mortality, nonfatal myocardial infarction or nonfatalstroke) was compared between genotype groups, and interaction with verapamil SR therapy was assessed.
12
Patients with fatal stroke had a lower CS, CBS and ASPECTS in the cerebral blood volume (CBV) and time-to-peak maps than those with nonfatalstroke.
13
The trial will continue until 1,360 confirmed primary composite cardiovascular end points, defined as cardiovascular death, nonfatal myocardial infarction, or nonfatalstroke, have occurred.